Ffr Intas is one of the world’s major global pharmaceutical formulation development, manufacturing, and marketing firms. Intas is a French acronym meaning Intellectual and Technical Assets. Through the merger of the international pharmaceutical development, manufacturing, and marketing company Sanofi-Synthelabo with Aventis’s research laboratory. The new company took its name from its constituent parts: “Intellectual” for research, “Technical” for production facilities, and “Assets” for market access. Intas purchased two sites in Florida making it one of America’s leading vaccine manufacturers.
ffr intas newffr intaspharma com webste login info online
Intas is marketing itself as a global pharmaceutical company, however, it is really a very small part of the French drug giant Sanofi-Synthelabo. The company manufactures primarily for the US market but has some capacity for EU sales as well. That said, Intas does not have its own distribution network in Europe and therefore manufactures through third-party distributors. Sanofi-Synthelabo has many companies operating in other countries, such as India or Brazil which benefit from economies of scale.
More about the ffr intas:
Intas ffr intas is a French multinational global pharmaceuticals firm headquartered in the 8th arrondissement of Paris. It is globally one of the largest international manufacturing organisations, being ranked third by revenue. The company furthermore focuses on marketing pharmaceuticals in North America and Europe. In 2007, the organization’s revenue was €10.45 billion with most revenue coming from its main markets; Europe and North America, where almost half of its revenue came from sales in each region.
How does it work?
Effectiveness is the result of heavy research and experimentation. In its most basic form, Intas uses a comprehensive global network to design, develop, and produce medication with the objective of improving human health. This network is composed of two main branches: research laboratories and production facilities. Intas is able to complete clinical trials undertaken in France in as little as six months from start to finish, whereas it takes an average of eight years for a drug to be approved by the Food and Drug Administration (FDA) in America. The drug development process begins with an initial idea or hypothesis that the organisation decides to pursue.
Why use it?
The French research center Intras is located in Dijon, France with a staff of over 2000 people and $1.16 billion in annual revenue. The production facilities are at La Ferté-Imbault, France, and are responsible for the creation of many prescription medications used to treat cancer, diabetes, heart disease, and infections. In America, Intas Pharmaceuticals Inc. has a global sales network that spans 150 countries resulting in quick delivery of medications to area clinics, hospitals, and consumers within the region.
It is from medical research and clinical trials that pharmaceuticals begin development. Intas’s production facilities focus on the manufacture of prescription pharmaceuticals, and these can be almost 100 percent complete within a span of six months. The organisation assumes this allows its drugs to reach the market on time and provides it revenue from sales in pre-marketing clinical trials, which are often significant. The company furthermore has been awarded a large number of patents for its drugs.
Tiffany is a Medical Student and also works as a fitness coach in part-time. She is also a writer and writes on health and fitness articles. Tiffany loves to engage with users and help them provide various useful information on General Health. She provides researched-based information and also featured on various blogs and magazines.